Natixis’s Biostar Pharmaceuticals BSPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
– Sell
-3,829
Closed -$54K – 565
2014
Q1
$54K Buy
3,829
+2,115
+123% +$33.5K ﹤0.01% 489
2013
Q4
$24K Buy
+1,714
New +$18.5K ﹤0.01% 560

Other funds holding BSPM

Natixis's BSPM Position: Q2 2014 in Review

Natixis sold out of Biostar Pharmaceuticals (BSPM) in Q2 2014, closing a stake of 3,829 shares — an estimated $54K sold.

Natixis first reported a position in BSPM in Q4 2013 and held it in 2 quarters. The position peaked at $54K in Q1 2014. 13 funds tracked by Wall St. Rank hold BSPM as of Q2 2014.

  • Natixis reported no remaining Biostar Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Natixis sold 3,829 Biostar Pharmaceuticals shares in Q2 2014, an estimated $54K.
  • Natixis first reported a position in Biostar Pharmaceuticals in Q4 2013 and held it in 2 quarters.
  • Natixis's Biostar Pharmaceuticals position peaked at $54K in Q1 2014.
  • 13 funds tracked by Wall St. Rank held Biostar Pharmaceuticals as of Q2 2014.

Based on Natixis's 13F filing for Q2 2014, filed 14 Aug 2014.